...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response
【24h】

Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response

机译:抗磷脂综合征的复发性血栓形成可能与心血管危险因素和炎症反应有关

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Antiphospholipid syndrome (APS) is a pro-thrombotic autoimmune disease that affects different vascular beds, with potential risk for recurrence. Systemic lupus erythematosus (SLE), specific autoantibodies profile and atherogenic disorders have been described as risk factors for the occurrence of first thrombosis in patients with antiphospholipid antibodies (aPL). However, factors associated with recurrent thrombosis have not yet been completely elucidated in APS. The aim of this study was to evaluate the association of recurrent thrombosis with markers of inflammation, autoimmunity and the presence of atherogenic disorders in APS patients.
机译:简介:抗磷脂综合征(APS)是一种促血栓性自身免疫疾病,会影响不同的血管床,并具有复发的潜在风险。系统性红斑狼疮(SLE),特定的自身抗体谱和动脉粥样硬化性疾病已被描述为抗磷脂抗体(aPL)患者发生首次血栓形成的危险因素。但是,与复发性血栓形成相关的因素尚未在APS中得到完全阐明。这项研究的目的是评估复发性血栓形成与APS患者炎症,自身免疫性标记物和动脉粥样硬化性疾病的存在之间的关系。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号